516.24—Granting MUMS-drug designation.
               		
               	 	
               	 	
               	 	               	 	               	 	               	 	               	 	
               	 	
    
        
        (a) 
         FDA may grant the request for MUMS-drug designation if none of the reasons described in  § 516.25 for refusal to grant such a request apply.
     
    
        
        (b) 
         When a request for MUMS-drug designation is granted, FDA will notify the sponsor in writing and will give public notice of the MUMS-drug designation in accordance with  § 516.28.